Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation

被引:139
作者
Hart, Robert G.
Pearce, Lesly A.
Aguilar, Maria I.
机构
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA
[2] Mayo Clin Scottsdale, Phoenix, AZ 85054 USA
关键词
D O I
10.7326/0003-4819-147-8-200710160-00018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:590 / 592
页数:3
相关论文
共 14 条
[1]   Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial [J].
Connolly, S. ;
Pogue, J. ;
Hart, R. ;
Pfeffer, M. ;
Hohnloser, S. ;
Chrolavicius, S. ;
Yusuf, S. .
LANCET, 2006, 367 (9526) :1903-1912
[2]   Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation - Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study [J].
Gullov, AL ;
Koefoed, BG ;
Petersen, P ;
Pedersen, TS ;
Andersen, ED ;
Godtfredsen, J ;
Boysen, G .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (14) :1513-1521
[3]   Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation [J].
Hart, Robert G. ;
Pearce, Lesly A. ;
Aguilar, Maria I. .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) :857-867
[4]   Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin [J].
Hellemons, BSP ;
Langenberg, M ;
Lodder, J ;
Vermeer, F ;
Schouten, HJA ;
van Ree, JW ;
Knottnerus, JA .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7215) :958-964
[5]  
Hu Da-yi, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P295
[6]  
KOUDSTAAL PJ, 1993, LANCET, V342, P1255
[7]   Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial [J].
Mant, Jonathan ;
Hobbs, F. D. Richard ;
Fletcher, Kate ;
Roalfe, Andrea ;
Fitzmaurice, David ;
Lip, Gregory Y. H. ;
Murray, Ellen .
LANCET, 2007, 370 (9586) :493-503
[8]  
MCBRIDE R, 1994, LANCET, V343, P687
[9]   Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation [J].
Morocutti, C ;
Amabile, G ;
Fattapposta, F ;
Nicolosi, A ;
Matteoli, S ;
Trappolini, M ;
Cataldo, G ;
Milanesi, G ;
Lavezzari, M ;
Pamparana, F ;
Coccheri, S .
STROKE, 1997, 28 (05) :1015-1021
[10]   Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation -: A randomized multicenter study [J].
Pérez-Gómez, F ;
Alegría, E ;
Berjón, J ;
Iriarte, JA ;
Zumalde, J ;
Salvador, A ;
Mataix, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (08) :1557-1566